1. Home
  2. OBIO vs SBFG Comparison

OBIO vs SBFG Comparison

Compare OBIO & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • SBFG
  • Stock Information
  • Founded
  • OBIO 2017
  • SBFG 1983
  • Country
  • OBIO United States
  • SBFG United States
  • Employees
  • OBIO N/A
  • SBFG N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • SBFG Major Banks
  • Sector
  • OBIO Health Care
  • SBFG Finance
  • Exchange
  • OBIO Nasdaq
  • SBFG Nasdaq
  • Market Cap
  • OBIO 151.3M
  • SBFG 128.3M
  • IPO Year
  • OBIO N/A
  • SBFG N/A
  • Fundamental
  • Price
  • OBIO $2.65
  • SBFG $19.60
  • Analyst Decision
  • OBIO Strong Buy
  • SBFG
  • Analyst Count
  • OBIO 5
  • SBFG 0
  • Target Price
  • OBIO $14.20
  • SBFG N/A
  • AVG Volume (30 Days)
  • OBIO 959.6K
  • SBFG 23.5K
  • Earning Date
  • OBIO 05-16-2025
  • SBFG 05-01-2025
  • Dividend Yield
  • OBIO N/A
  • SBFG 2.96%
  • EPS Growth
  • OBIO N/A
  • SBFG N/A
  • EPS
  • OBIO N/A
  • SBFG 1.70
  • Revenue
  • OBIO $2,638,000.00
  • SBFG $58,812,000.00
  • Revenue This Year
  • OBIO $13.87
  • SBFG N/A
  • Revenue Next Year
  • OBIO $32.19
  • SBFG N/A
  • P/E Ratio
  • OBIO N/A
  • SBFG $11.51
  • Revenue Growth
  • OBIO N/A
  • SBFG 4.73
  • 52 Week Low
  • OBIO $2.43
  • SBFG $13.01
  • 52 Week High
  • OBIO $8.87
  • SBFG $24.48
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 43.61
  • SBFG 52.02
  • Support Level
  • OBIO $2.37
  • SBFG $18.53
  • Resistance Level
  • OBIO $2.99
  • SBFG $19.89
  • Average True Range (ATR)
  • OBIO 0.33
  • SBFG 0.77
  • MACD
  • OBIO 0.05
  • SBFG 0.09
  • Stochastic Oscillator
  • OBIO 32.18
  • SBFG 72.89

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About SBFG SB Financial Group Inc.

SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.

Share on Social Networks: